- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03263286
Home Therapy for Stroke Rehabilitation Using the HandSOME Exoskeleton (HandSOME)
August 26, 2020 updated by: The Catholic University of America
Home Therapy for Upper Limb Stroke Rehabilitation Using the HandSOME Exoskeleton
This research will evaluate the potential for a novel hand orthosis (HandSOME) to help stroke victims regain functional use of their hand and regain independent living.
Participants will use the HandSOME at home regularly for 8 weeks.
Clinical evaluations will measure changes from the intervention after the 8 weeks and also at a 3 month followup.
Study Overview
Detailed Description
After stroke, individuals often have great difficulty with using the affected hand in functional tasks.
The hand frequently suffers from finger flexor hypertonia as well as finger extensor weakness.
This leads to increased difficulty in grasp and release of objects.
HandSOME is a light weight wearable hand orthosis that increases range of motion and decreases effort during grasping tasks.
The goal of this study is to evaluate the HandSOME device's effectiveness in the rehabilitation of stroke patients through an 8 week intervention.
Eligible subjects will use the device daily at home for 8 weeks with one visit per week to the clinic to evaluate progress and troubleshoot problems with the device.
The hypotheses are that the gains from the 8 weeks of training will be statistically significant and clinically important (defined as gains of greater than 10% of full scale) in the domains of impairment, function and amount of arm use.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- MedStar National Rehabilitation Network
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of stroke more than six months prior to entry into the study
- Impaired ability to open affected the hand
- At least trace ability to extend the wrist and fingers
Exclusion Criteria:
- Have cognitive deficits that could negatively affect their ability to complete the protocols as evidenced by a score of 24 or less on the Folstein Mini-Mental State Examination
- Have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols
- Have serious uncontrolled medical problems as judged by the project therapist
- Receiving oral or injected antispasticity medications during study treatment
- MCP and IP passive extension limit > 30 degrees from full extension
- Excessive tone in the fingers and thumb as determined by Ashworth scores >=3
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: HandSOME
The intervention is given to this group.
|
Participants use the HandSOME orthosis daily for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Fugl-Meyer Test of Arm Function
Time Frame: Change from baseline Fugl-Meyer score at 2 months
|
clinical test of arm motor ability and impairment
|
Change from baseline Fugl-Meyer score at 2 months
|
Change in Action Research Arm Test
Time Frame: Change from baseline Action Research Arm Test score at 2 months
|
clinical test of the functional limitations of the upper extremities
|
Change from baseline Action Research Arm Test score at 2 months
|
Change in Motor Activity Log
Time Frame: Change from baseline Motor Activity Log score at 2 months
|
assess the amount and quality of limb use at home
|
Change from baseline Motor Activity Log score at 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Fugl-Meyer Test of Arm Function at followup
Time Frame: Change from baseline Fugl-Meyer score at 5 months
|
clinical test of arm motor ability and impairment
|
Change from baseline Fugl-Meyer score at 5 months
|
Change in Action Research Arm Test at followup
Time Frame: Change from baseline Action Research Arm Test score at 5 months
|
clinical test of the functional limitations of the upper extremities
|
Change from baseline Action Research Arm Test score at 5 months
|
Change in Motor Activity Log at followup
Time Frame: Change from baseline Motor Activity Log score at 5 months
|
assess the amount and quality of limb use at home
|
Change from baseline Motor Activity Log score at 5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2017
Primary Completion (Actual)
October 7, 2019
Study Completion (Actual)
October 7, 2019
Study Registration Dates
First Submitted
August 21, 2017
First Submitted That Met QC Criteria
August 23, 2017
First Posted (Actual)
August 28, 2017
Study Record Updates
Last Update Posted (Actual)
August 28, 2020
Last Update Submitted That Met QC Criteria
August 26, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-064
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamActive, not recruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationActive, not recruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey